ClinicalTrials.gov · NCT03353597 · Unknown status
Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects
Registry record
NCT03353597 on ClinicalTrials.gov. The registry's last update to this record was 17 January 2018.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor Chandra Duggirala Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Plasma Transfusion Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Biological age as assessed by DNA methylation levels, to calculate the Epigenetic age. Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Unknown status Checked Source clinicaltrials.gov Overall status as registered; registry last update 2018-01-17. Checked
Check history: NCT03353597 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: Chandra Duggirala
- Phase: Phase 1, Phase 2
- Status: Unknown status
- Intervention: Plasma Transfusion
- Primary outcome: Biological age as assessed by DNA methylation levels, to calculate the Epigenetic age.
- Countries: United States
- Start: 15 May 2018
- Completion (estimated): 15 December 2022
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.